{
    "title": "J&J eyes 1 bln doses of potential COVID-19 shot in 2021, weighs challenge trials",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8616267/J-J-eyes-1-bln-doses-potential-COVID-19-shot-2021-weighs-challenge-trials.html",
    "date": "2020-08-11",
    "keywords": [
        "vaccine",
        "jampj",
        "van",
        "hoof",
        "virus",
        "covid19",
        "year",
        "coronavirus",
        "company",
        "candidate",
        "janssen",
        "beginning",
        "end",
        "transmission",
        "challenge",
        "guarascio",
        "johnson",
        "executive",
        "july",
        "earlystage",
        "safety",
        "study",
        "bestperforming",
        "protection",
        "dose",
        "collaboration",
        "subsidiary",
        "october",
        "efficacy",
        "mid2021",
        "johan",
        "head",
        "tuesday",
        "telephone",
        "interview",
        "president",
        "vladimir",
        "putin",
        "russia",
        "country",
        "approval",
        "production",
        "capacity",
        "approach",
        "decision",
        "booster",
        "largescale",
        "phase",
        "incidence",
        "latin",
        "number",
        "possibility",
        "instance",
        "therapy",
        "disease",
        "drugmaker",
        "astrazeneca",
        "oxford",
        "university",
        "trial",
        "pathogen",
        "option",
        "snag",
        "stock",
        "part",
        "idea",
        "community",
        "reporting",
        "sitholematarise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}